重型穿透性脑损伤管理中颅内压监测与不监测的比较效果
该比较效果研究分析美国国家创伤数据库2017年1月1日至2019年12月31日数据,纳入596例重型穿透性脑损伤患者(GCS<9持续24小时、ICU停留>2天、头AIS 3-5分且其他部位AIS<3分),比较颅内压监测与不监测的结局。倾向性评分匹配后466例(每组233例),颅内压监测组死亡率30.9%(72例)低于不监测组40.8%(95例),OR 1.54(95%CI 1.05-2.25;P=0.03;NNT=10);倾向性评分加权分析全部596例,OR 1.40(95%CI 1.10-1.78;P=0.005)。颅内压监测组ICU住院时间中位数延长(15.0天 vs 7.0天;P<0.001),两组出院去向良好率无差异。作者认为该结果挑战了穿透性脑损伤普遍预后不良的观念,并认为需要随机临床试验评估颅内压监测的疗效。
要点
- 在GCS<9持续24小时的重型穿透性脑损伤患者中,颅内压监测组死亡率30.9%(72例)低于不监测组40.8%(95例),OR 1.54(95%CI 1.05-2.25;P=0.03),NNT=10。
- 倾向性评分加权分析全部596例显示颅内压监测与较高生存率相关(OR 1.40;95%CI 1.10-1.78;P=0.005)。
- 颅内压监测组ICU住院时间中位数15.0天(IQR 8.0-21.0)长于不监测组7.0天(IQR 4.0-12.0),P<0.001。
- 两组出院去向良好率无差异。
- 作者认为需要随机临床试验评估颅内压监测在穿透性脑损伤中的疗效。
适用人群与场景
- 纳入标准:年龄16至60岁(原文写作「aged 16 and 60 years」),穿透性脑损伤,ICU停留时间超过2天,到达时和24小时GCS评分低于9分,头部简明损伤定级(AIS)评分3至5分且其他身体部位AIS评分低于3分。
- 排除标准:双侧瞳孔固定或数据不完整者。
- 研究场景:美国国家创伤数据库创伤质量改进项目(2017年1月1日至2019年12月31日)中的住院患者。
诊断标准与关键阈值
- 重型穿透性脑损伤定义基于:ICU停留时间超过2天、到达时和24小时GCS评分低于9分、头部AIS评分3至5分且其他部位AIS评分低于3分。
处置流程与药物剂量
- 暴露因素:颅内压监测与不监测。
红旗征与不能漏的情况
- 双侧瞳孔固定为排除标准。
研究设计与关键结果
- 研究类型:比较效果研究,分析美国国家创伤数据库创伤质量改进项目2017年1月1日至2019年12月31日数据;倾向性评分1:1匹配;数据分析时间为2022年9月至12月。
- 样本量:共纳入596例患者(男性505例[84.7%];平均[SD]年龄32.2[12.3]岁),其中220例(36.9%)死亡,288例(48.3%)接受颅内压监测。
- 倾向性评分匹配后纳入466例(颅内压监测组233例 vs 不监测组233例);总死亡率为35.8%;颅内压监测组72例(30.9%)死亡,不监测组95例(40.8%)死亡。
- 颅内压监测组患者更可能存活(OR 1.54;95%CI 1.05-2.25;P=0.03;需治疗人数=10)。
- 两组出院去向良好率无差异。
- 倾向性评分加权分析纳入全部596例患者,颅内压监测组较不监测组更可能存活(OR 1.40;95%CI 1.10-1.78;P=0.005)。
- 基于倾向性评分匹配数据集的OR计算的E值为1.79。
- 颅内压监测与不监测相比,ICU住院时间中位数(IQR)延长(15.0[8.0-21.0]天 vs 7.0[4.0-12.0]天;P<0.001)。
证据类型、等级与局限
- 证据类型:比较效果研究(基于美国国家创伤数据库的回顾性分析)。
- 局限:原文未报告局限性;作者在结论中提出需要随机临床试验评估颅内压监测在穿透性脑损伤中的疗效。
对床旁实践的改变
- 作者认为,由颅内压监测指导的重型穿透性脑损伤管理可能与死亡率降低相关,但ICU住院时间延长,挑战了平民穿透性脑损伤普遍预后不良的观念;作者认为需要随机临床试验评估颅内压监测的疗效。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Civilian penetrating brain injury (PBI) is associated with high mortality. However, scant literature is available to guide neurocritical care monitoring and management of PBI.
OBJECTIVE: To examine the association of intracranial pressure (ICP) monitoring with mortality, intensive care unit (ICU) length of stay (LOS), and dispositional outcomes in patients with severe PBI.
DESIGN, SETTING, AND PARTICIPANTS: This comparative effectiveness research study analyzed data from the Trauma Quality Improvement Program of the National Trauma Data Bank in the US from January 1, 2017, to December 31, 2019. Patients with PBI were identified, and those aged 16 and 60 years who met these inclusion criteria were included: ICU LOS of more than 2 days, Glasgow Coma Scale (GCS) score lower than 9 on arrival and at 24 hours, and Abbreviated Injury Scale score of 3 to 5 for the head region and lower than 3 for other body regions. Patients with bilaterally fixed pupils or incomplete data were excluded. A 1:1 propensity score (PS) matching was used to create a subgroup of patients. Patients were divided into 2 groups: with vs without ICP monitoring. Data analysis was conducted between September and December 2022.
EXPOSURES: Intracranial pressure monitoring vs no monitoring.
MAIN OUTCOMES AND MEASURES: Outcomes were mortality, rate of withdrawal, ICU LOS, and dispositional outcome. Measures were age, initial systolic blood pressure, initial oxygen saturation level on a pulse oximeter, first-recorded GCS score, GCS score at 24 hours, Abbreviated Injury Scale score, midline shift, and pupillary reactivity.
RESULTS: A total of 596 patients (505 males [84.7%]; mean [SD] age, 32.2 [12.3] years) were included, among whom 220 (36.9%) died and 288 (48.3%) had ICP monitoring. The PS matching yielded 466 patients (233 in each group with vs without ICP monitoring). Overall mortality was 35.8%; 72 patients with ICP monitoring (30.9%) died compared with 95 patients (40.8%) without ICP monitoring . Patients with ICP monitoring were more likely to survive (odds ratio [OR], 1.54; 95% CI, 1.05-2.25; P = .03; number needed to treat, 10). No difference in favorable discharge disposition was observed. The PS-weighted analysis included all 596 patients and found that patients with ICP monitoring were more likely to survive than those without (OR, 1.40; 95% CI, 1.10-1.78; P = .005). The E-value for the OR calculated from the PS-matched data set was 1.79. In addition, ICP monitoring vs no monitoring was associated with an increase in median (IQR) ICU LOS (15.0 [8.0-21.0] days vs 7.0 [4.0-12.0] days; P < .001).
CONCLUSIONS AND RELEVANCE: In this comparative effectiveness research study, PBI management guided by ICP monitoring was associated with decreased mortality and increased ICU LOS, challenging the notion of universally poor outcomes after civilian PBI. Randomized clinical trials that evaluate the efficacy of ICP monitoring in PBI are warranted.
参考来源
- Mansour A, Rowell S, Powla PP, et al. Comparative Effectiveness of Intracranial Pressure Monitoring vs No Monitoring in Severe Penetrating Brain Injury Management. JAMA Netw Open. 2023. PMID: 36961466. doi:10.1001/jamanetworkopen.2023.1077
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。